Listed times are in Central European Summer Time (CEST)

REGISTRATION

Light refreshments will be served at 12:00

CONFERENCE WELCOME

Session 1: Unveiling the biology beneath the biomarkers: Mechanisms driving liquid biopsy signals

Chair: Ellen Heitzer

OPENING KEYNOTE LECTURE

Efrat Shema Weizmann Institute of Science, Israel

'Single-molecule epigenetic analysis of plasma-circulating nucleosomes for cancer diagnosis'

Q&A 13:40-13:55

Amin El-Heliebi Med Uni Graz, Austria

'Integrating liquid biopsy and spatial transcriptomics for understanding ctDNA release'

Q&A 14:15-14:25

Proferred Paper 1

Q&A 14:35-14:40

EXHIBITOR INTRODUCTIONS

COFFEE BREAK, EXHIBITION AND SOLO TRAVELLERS' MEET-UP

Remond Fijneman NKI, Netherlands

'Impact of tumor location and host factors on ctDNA shedding'

Q&A 15:40-15:50

David Lyden Weill Cornell Medicine, USA

Q&A 16:10-16:20

POSTER SPOTLIGHTS

INDUSTRY SYMPOSIUM - biomodal

PANEL DISCUSSION

'Where is liquid biopsy heading in the next 5–10 years? Clinical implementation, standardization and regulatory challenges'

WELCOME RECEPTION

POSTER DISCUSSION SESSION 1

Led by members of the Scientific Programme Committee

Listed times are in Central European Summer Time (CEST)

EARLY POSTER VIEWING

Chair: Claus Lindbjerg Andersen

INDUSTRY SPOTLIGHT - Ultima Genomics

Session 2: Tracking the unseen: Liquid biopsies in advanced and metastatic cancer

Karen-Lise Garm Spindler Aarhus University, Denmark

'Using ctDNA for response evaluation in solid tumors – a paradigm shift in medical oncology?'

Q&A 9:20-9:30

Proferred Paper 2

Q&A 09:40-09:45

Ellen Heitzer Meduni Graz, Austria

'Signal vs Noise: The Reality of ctDNA in Advanced Disease'

Q&A 10:05-10:15

Irene Casanova VHIO, Spain

'EV-enhanced liquid biopsy for tumor dynamics in metastatic Prostate Cancer'

Q&A 10:35-10:45

COFFEE BREAK AND EXHIBITION

François Clément Bidard Institut Curie & UVSQ/Université Paris-Saclay, France

'Intercepting late resistance to therapy with ctDNA: ESR1 mutations and beyond'

Q&A 11:35-11:45

Proferred Paper 3

Q&A 11:55-12:00

POSTER SPOTLIGHTS

INDUSTRY SYMPOSIUM - Becton Dickinson

LUNCH

POSTER DISCUSSION SESSION 2

Led by members of the Scientific Programme Committee

Session 3: Frontiers in liquid biopsy technology: From fragmentomics to functional readouts

Chair: Nikolas Stoecklein

Mette Aaegebeck University of Copenhagen, Denmark

'Oncofetal Chondroitin Sulfate: A circulating biomarker on tumour-derived CTCs, EVs, and soluble proteoglycans'

Q&A 15:20-15:30

Proferred Paper 4

Q&A 15:40-15:45

Proferred Paper 5

Q&A 15:55-16:00

Nikolas H. Stoecklein University of Dusseldorf, Germany

'From Milliliters to Liters of Blood: Diagnostic Leukapheresis as a Platform for Scaled CTC Discovery and Translation'

Q&A 16:20-16:30

COFFEE BREAK AND EXHIBITION

An Hendrix Ghent University, Belgium

Q&A 17:20-17:30

Anders Jacobsen Skanderup Genome Institute of Singapore, Singapore

'Pushing the Limits: Enhancing Detection and Quantification in Tumour-Naive Liquid Biopsies'

Q&A 17:50-18:00

PANEL DISCUSSION

'Publication strategies and the responsible use of AI in scientific writing'

Scheduled to end at 18:45

CONFERENCE DINNER (OPTIONAL TICKETED EVENT)

Listed times are in Central European Summer Time (CEST)

EARLY POSTER VIEWING

Chair: An Hendrix

INDUSTRY SPOTLIGHT - Particle Metrix

Session 4: Liquid insights at the earliest stage: Transforming localised cancer detection and intervention

Angela DeMichele Penn Medicine, USA

'ctDNA in the neoadjuvant and adjuvant management of breast cancer: the quest for clinical utility'

Q&A 09:20-09:30

Claus Lindbjerg Andersen Aarhus University, Denmark

'From Resection to Recurrence Prediction: The Role of Liquid Biopsy in CRC Management'

Q&A 09:50-10:00

Proferred Paper 6

Q&A 10:10-10:15

COFFEE BREAK AND EXHIBITION

Nickolas Papadopoulos John Hopkins Medicine, USA

Q&A 11:05-11:15

CLOSING KEYNOTE LECTURE

Maximilian Diehn Stanford University, USA

'Analysis of cell-free RNA for cancer detection and characterization'

Q&A 11:45-12:00

SUMMARY AND CLOSE